Highlights GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

End-of-day quote Korea S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
2,260 ^KRW	-0.88%		-3.42%	-20.42%

16/05	GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
28/03	GeneOne Life Science, Inc. announced that it has received KRW 3.6000014 billion in funding	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
GeneOne Life Science, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
GeneOne Life Science, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	08/21/08	CI
VGX Pharmaceuticals, Inc. Terminates CELLECTRA Device License Agreement with GeneOne	16/20/16	CI
INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data with DNA Vaccine INO-4700 for MERS Coronavirus a the American Society of Gene & Cell Therapy Conference	29/20/29	CI
Inovio and Korean Partner Dose 1st Subject In Trial to Develop Vaccine to Prevent Hepatitis C Infection	04/18/04	CI
GeneOne Life Science Inc. Announces Full Enrollment of First-In-Human Study of MERS Vaccine	09/16/09	CI
Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial	20/16/20	CI
Inovio Pharmaceuticals and GeneOne Life Science Initiate Patient Recruitment for MERS Vaccine Trial	28/16/28	CI
GeneOne Life Science Announces Initiation of Collaborative Research Program with Inovio Pharmaceuticals	22/16/22	CI
GeneOne Life Science Inc. and Inovio Pharmaceuticals, Inc. Receive Clearance from U.S. Food and Drug Administration for First-in-Human Clinical Study of its Collaborative Vaccine for MERS	19/15/19	CI
GeneOne Life Science Inc. and the Walter Reed Army Institute of Research Partner to Develop MERS Vaccine	11/15/11	CI
Inovio Pharmaceuticals, Inc. Partners with Geneone Life Science Inc. for MERS Immunotherapy Clinical Development	27/15/27	CI
Inovio Pharmaceuticals, Inc. Announces Phase I Clinical Trial for Ebola in Collaboration with GeneOne Life Science Inc	24/14/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GeneOne Life Science, Inc.

Equities

A011000

KR7011000007

Highlights

Filters